How should a patient with a chronic anal fissure refractory to at least 6 weeks of optimized medical therapy (topical nitroglycerin or calcium channel blocker, stool softeners, high‑fiber diet, and analgesia) be managed, including pre‑operative preparation, fissurectomy technique, and postoperative care?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Chronic Anal Fissure Refractory to Medical Therapy

For chronic anal fissure that has failed 6 weeks of optimized medical therapy, lateral internal sphincterotomy (LIS) is the definitive treatment of choice, offering >95% healing rates with low recurrence (1-3%), though patients must be counseled about the risk of minor permanent incontinence. 1

Surgical Decision-Making Algorithm

When to Proceed to Surgery

After 6 weeks of failed medical therapy (topical nitroglycerin or calcium channel blockers, fiber, stool softeners), you have three options:

  1. Lateral Internal Sphincterotomy (LIS) - First choice for most patients
  2. Botulinum toxin injection - Consider if incontinence risk is high
  3. Extended medical therapy - Only if patient refuses surgery

Patient Selection for LIS vs. Botulinum Toxin

Choose LIS for:

  • Normal baseline continence
  • Desire for definitive cure
  • Failed medical therapy with persistent severe pain
  • Young, healthy patients

Choose Botulinum Toxin for:

  • Any baseline continence issues
  • Multiparous women
  • Elderly patients
  • Previous anal surgery
  • Patient preference to avoid permanent sphincter division

The guideline evidence shows botulinum toxin achieves 75-95% cure rates 1, while LIS achieves >95% 1. However, LIS carries risk of permanent minor incontinence defects in a minority of patients, whereas botulinum toxin only causes transitory mild incontinence 2.

Pre-operative Preparation

Clinical Assessment

  • Confirm chronicity: Look for sentinel tag, hypertrophied papilla, fibrosis, or visible internal sphincter muscle at fissure base 1
  • Verify midline location: Off-midline fissures mandate workup for Crohn's disease, HIV/AIDS, tuberculosis, syphilis, leukemia, or cancer before proceeding 1
  • Assess continence: Detailed history of any gas/stool leakage, urgency, or soiling

Patient Counseling

Explicitly discuss:

  • Success rates: LIS cures >95% with 1-3% recurrence 1, 2
  • Incontinence risk: Minor but sometimes permanent defects in continence can occur 1
  • Alternative: Botulinum toxin is nearly as effective (81.8% in one study 3) without permanent incontinence risk

Pre-operative Orders

  • Standard bowel preparation not required
  • Continue fiber supplementation through perioperative period
  • Prophylactic antibiotics per institutional protocol

Surgical Technique: Lateral Internal Sphincterotomy

Positioning and Anesthesia

  • Prone jackknife or lithotomy position
  • General, spinal, or local anesthesia acceptable

Operative Steps

  1. Identify the intersphincteric groove laterally (3 or 9 o'clock position)
  2. Open or closed technique (surgeon preference):
    • Closed: Insert blade into intersphincteric groove, divide internal sphincter fibers up to dentate line
    • Open: Make small radial incision, directly visualize and divide internal sphincter
  3. Extent of division: Divide internal sphincter from anal verge to dentate line (NOT beyond)
  4. Hemostasis: Achieve meticulous hemostasis
  5. Wound management: Leave open to heal by secondary intention

Critical Technical Points

  • Never divide external sphincter
  • Avoid posterior location to prevent keyhole deformity
  • Limit sphincterotomy length to dentate line to minimize incontinence risk
  • Do not excise the fissure itself unless performing fissurectomy for specific indication

Alternative: Fissurectomy Technique

While the provided guidelines favor LIS 1, recent evidence suggests fissurectomy alone (without sphincterotomy) may be preferred in German-speaking countries due to lower incontinence risk 4, with 80% success rates. This involves:

  1. Excise the fissure and any sentinel tag
  2. Excise hypertrophied papilla if present
  3. May combine with advancement flap if needed
  4. Do not divide sphincter

This is particularly appropriate for patients with any continence concerns 5, 4.

Postoperative Care

Immediate Post-operative Period

  • Pain management: Oral analgesics (NSAIDs, acetaminophen, short-course opioids if needed)
  • Sitz baths: 2-3 times daily, especially after bowel movements
  • First bowel movement: Encourage within 24-48 hours to prevent constipation

Ongoing Management (Weeks 1-6)

  • Fiber supplementation: Continue 20-30g daily indefinitely
  • Stool softeners: Maintain soft, formed stools
  • Adequate hydration: 8-10 glasses water daily
  • Sitz baths: Continue until wound healed
  • Activity: Resume normal activities as tolerated; avoid heavy lifting for 2 weeks

Follow-up Schedule

  • 2 weeks: Assess healing, pain control, bowel function
  • 6-8 weeks: Confirm complete healing, assess continence

Monitoring for Complications

Early complications:

  • Urinary retention (especially with spinal anesthesia)
  • Bleeding
  • Infection (rare)

Late complications:

  • Incontinence: Question specifically about gas, liquid, or solid stool leakage
  • Recurrence (1-3% with LIS 1, 2)
  • Delayed wound healing

Common Pitfalls and How to Avoid Them

Pitfall 1: Operating on Undiagnosed Crohn's Disease

Avoidance: Always evaluate off-midline fissures for underlying disease before surgery 1

Pitfall 2: Excessive Sphincterotomy

Avoidance: Limit division to dentate line only; never divide external sphincter

Pitfall 3: Ignoring Baseline Continence Issues

Avoidance: Detailed pre-operative continence assessment; consider botulinum toxin or fissurectomy alone in at-risk patients 2, 5

Pitfall 4: Inadequate Postoperative Bowel Regimen

Avoidance: Aggressive fiber/stool softener regimen must continue for months, not just weeks

Special Considerations

If patient refuses surgery: Consider botulinum toxin injection into internal sphincter (81.8% healing 3) or extended trial of calcium channel blockers (fewer side effects than nitroglycerin 1, 6)

If fissure recurs after LIS: Re-evaluate for Crohn's disease, inadequate sphincterotomy, or poor bowel habits; may require repeat procedure or fissurectomy with advancement flap

Pregnancy/lactation: These were exclusion criteria in recent studies 7; defer surgery until postpartum if possible

References

Research

Chronic Anal Fissure.

Current treatment options in gastroenterology, 2003

Research

Medical and surgical treatment of chronic anal fissure: a prospective study.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2007

Research

[Chronic anal fissure-Cremes or surgery?].

Chirurgie (Heidelberg, Germany), 2025

Research

[Management of anal fissure].

La Revue du praticien, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.